What's happening
This bill adds tianeptine sodium to New York’s schedule II list of controlled substances.
Why it matters
Classifying tianeptine sodium as a Schedule II controlled substance would significantly restrict its availability, meaning it could only be legally prescribed and dispensed under strict regulations, similar to other drugs with high abuse potential but accepted medical uses.
The measure is a response to increasing concerns about misuse and addiction associated with tianeptine, which is often marketed online as a 'supplement' but has been linked to opioid-like effects and withdrawal symptoms.
Pharmacies, healthcare providers, and law enforcement would need to update their practices and monitoring systems to track tianeptine sodium, potentially reducing illicit sales and unregulated access in New York.
Making tianeptine sodium a controlled substance may impact individuals who currently use it (legally or illegally), possibly prompting some to seek medical oversight, addiction treatment, or alternative therapies.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Ban Tianeptine Sodium
Plain English, a few words. Used as the page title.
Sponsors
Senator · Senate District 42
No co-sponsors yet.
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Ban Tianeptine Sodium Sales
In Assembly Committee · Health · Sponsor Edward Braunstein
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
1720
2023-2024 Regular Sessions
IN SENATE
January 13, 2023
Introduced by Sen. SKOUFIS -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law, in relation to adding tianeptine sodium to schedule II of controlled substances
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision (e) of schedule II of section 3306 of the public health law is amended by adding a new paragraph 5 to read as follows:
(5) Tianeptine sodium.
§ 2. This act shall take effect on the ninetieth day after it shall have become a law.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD04681-01-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to adding tianeptine sodium to schedule II of controlled substances
Purpose
Adds tianeptine sodium to the list of schedule II of controlled substances
Summary of provisions
Section 1: Subdivision (e) of schedule II of Section 3306 of the Public Health Law is amended by adding a new paragraph 5.
Section 2: sets forth the effective date.
Justification
Tianeptine sodium is an antidepressant that has not been approved by the United States Food and Drug Administration. It has also not been approved for medical use in Australia, Canada and the United Kingdom. However, it is still available for purchase online and is marketed as a supplement or research chemical. Tianeptine sodium is often abused in high doses to simulate opioid like highs and can lead to addiction coupled with withdrawal symptoms.
According to the Associated Press, Michigan became the first state to ban tianeptine sodium "after a spate of gruesome overdoses related to tianeptine sodium scoured the Midland and Saginaw area in 2017." Addi- tionally, the U.S. Centers for Disease Control and Prevention's Morbidi- ty and Mortality Weekly Report in August, 2018, reported there were 207 poison control center calls related to tianeptine sodium from 20142018, compared to only 11 calls in the previous 14 years.
The Associated Press reported that a substance abuse recovery coach testified before the Michigan State Senate about how her "addiction to tianeptine sodium affected her while weaning herself off heroin a proc- ess she said was far less horrific than tianeptine withdrawal. I could not get out of bed, go to work, have a normal functioning day without (tianeptine sodium) in my life. I am convinced that (it) is the next epidemic."
Legislative history
Senate
2020 - S8023, Referred to Health
2021-2022- S1776, Referred to Health
Assembly
2020- A7750, Referred to Health
2021-2022- A344, Referred to Health
Fiscal implications
None.
Effective date
This act shall take effect on the ninetieth day after it shall become law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.